Bimzelx 160 mg solution for injection in pre-filled pen clinical trials

A multicenter, open-label, prospective study to assess the concentration of bimekizumab in mature breast milk from mothers receiving treatment with Bimzelx® (bimekizumab)

This study looks at how much of the medicine, Bimzelx, gets into breast milk. It's for mothers with conditions like psoriasis or arthritis who are treated with Bimzelx, to understand if it's safe for their babies.